» Articles » PMID: 28314402

Management of Orbital Involvement in Sinonasal and Ventral Skull Base Malignancies

Overview
Date 2017 Mar 19
PMID 28314402
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The orbit may be frequently involved by sinonasal or ventral skull base malignancy. This involvement bodes a poorer prognosis for survival. Multimodality therapy with surgery and radiation therapy is usually attempted to optimize local control and overall survival. Oncologic surgical resection with negative margins is critical to local control and survival. In the past, any involvement of the orbit was deemed to necessitate orbital sacrifice. However, contemporary studies show that in carefully selected cases, orbital preservation does not adversely impact survival. In addition, novel reconstructive techniques can help minimize complications and optimize functional and aesthetic outcomes.

Citing Articles

Preservation of orbit in tumor invasion through the periorbita in sinonasal malignancy.

Novak S, Balatkova Z, Fikova A, Grega M, Kalfert D, Plzak J Eur Arch Otorhinolaryngol. 2024; 281(10):5303-5310.

PMID: 38914815 PMC: 11416355. DOI: 10.1007/s00405-024-08757-z.


Diagnostic performance of MRI for the assessment of extraocular muscle invasion in malignant sinonasal tumors.

Sun Z, Wang X, Wang Q, Xian J Eur Arch Otorhinolaryngol. 2023; 280(8):3687-3693.

PMID: 36811653 DOI: 10.1007/s00405-023-07874-5.


Treatment Outcomes of Sinonasal Malignancies Involving the Orbit.

Shin C, Lee H, Chung Y, Kim J J Neurol Surg B Skull Base. 2022; 83(Suppl 2):e430-e437.

PMID: 35832962 PMC: 9272286. DOI: 10.1055/s-0041-1730353.


The Selective Role of Open and Endoscopic Approaches for Sinonasal Malignant Tumours.

Lopez F, Shah J, Beitler J, Snyderman C, Lund V, Piazza C Adv Ther. 2022; 39(6):2379-2397.

PMID: 35352310 PMC: 9122878. DOI: 10.1007/s12325-022-02080-x.


Surgical Management of Sinonasal Cancers: A Comprehensive Review.

Chatelet F, Simon F, Bedarida V, Le Clerc N, Adle-Biassette H, Manivet P Cancers (Basel). 2021; 13(16).

PMID: 34439150 PMC: 8393312. DOI: 10.3390/cancers13163995.